# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Lake Street analyst Frank Takkinen initiates coverage on Sight Sciences (NASDAQ:SGHT) with a Buy rating and announces Price ...
Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) with a Hold.
The Company expects dry eye revenue for full year 2024 to be less than $3.0 million, including the $2.1 million of revenue achi...
However, the Company expects Dry Eye revenue to decrease as it implements an increase in dry eye pricing effective October 1, 2...
Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.30...
Morgan Stanley analyst Cecilia Furlong maintains Sight Sciences (NASDAQ:SGHT) with a Equal-Weight and raises the price targe...
Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $6 t...